Tricyclic antidepressant poisoning remains a major cause of morbidity and mortality, particularly in the setting of suicidal attempts. The current standard of care for treatment is the administration of sodium bicarbonate infusion. Adjunctive lipid emulsion therapy and plasmapheresis have received attention recently. We report an 18-year-old patient who was successfully managed with lipid emulsion and plasmapheresis as adjuncts to sodium bicarbonate treatment and review some of the recent literature.
T ricyclic antidepressant (TCA) poisoning presents a tremendous management challenge ( 1 ) . While the selective serotonin receptor inhibitors are now increasingly prescribed for the treatment of depression, TCAs still play a role in the treatment of other conditions including enuresis, obsessive compulsive disorder, attention defi cit hyperactivity, separation anxiety and neuralgic pain in children, and chronic pain and migraine in adults. Patients with suicidal ideation still seek TCAs as a way of attempting suicide ( 2 ) . If abused, euphoria, hallucination, and a distorted sense of time may result ( 1 ) . TCA overdose often represents a dire emergency with high mortality rates. Th e mainstay of management is the administration of intravenous sodium bicarbonate. Recently, adjunctive therapies, including intravenous lipid administration and emergent plasmapheresis ( 3 -7 ), have been increasingly used. We present a case of amitriptyline overdose with suicidal intent in a young patient with major depression.
CASE PRESENTATION
An 18-year-old man was brought to the emergency department after being found unresponsive at home with empty bottles of amitriptyline and venlafaxine. He had a medical history of severe depression and attention defi cit hyperactivity disorder, with three prior suicide attempts. His parents were not sure how many pills he had ingested. In the emergency department, he was minimally responsive to painful stimuli with sonorous respirations. His initial oxygen saturation was 70%. An initial electrocardiogram showed a widened QRS, prominent R waves in aVR, and frequent ventricular premature complexes ( Figure 1 ) . Within minutes of arrival, he went into cardiac arrest from ventricular fi brillation. He also had a witnessed generalized tonic clonic seizure during the episode of cardiopulmonary resuscitation. He was successfully resuscitated after receiving fi ve rounds of intravenous epinephrine, shocks, and two rounds each of naloxone and 8.4% sodium bicarbonate. Th e patient was responsive immediately upon return of spontaneous circulation. He was then treated with activated charcoal to attempt gastric decontamination and 20% intravenous lipid emulsion before being transported to the intensive care unit and continued on a sodium bicarbonate infusion.
Arterial blood gas analysis showed anion gap metabolic acidosis and respiratory acidosis. Th e patient was also treated with plasmapheresis on two occasions for the next two consecutive days. He remained hemodynamically unstable, requiring ventilator support and vasopressors. We also administered 2 g of intravenous magnesium sulphate to reduce the risk of recurrent ventricular arrhythmias. Serial 12-lead electrocardiograms were used to monitor his QT interval. His urine was positive for opiates and phencyclidine. Laboratory assay for acetaminophen and salicylate were unremarkable. An initial electrolyte panel revealed a serum potassium level of 5.8 mmol/L and serum creatinine of 2.39 mg/dL (reference range, 0.7-1.3), increased from his baseline of 0.93. Th e creatine kinase was 7350 U/L (reference range, 30-170) on presentation, peaking to 8162 on day 2.
In spite of aggressive treatment, the patient developed clinical and radiologic features of acute respiratory distress syndrome (ARDS). Serial chest x-rays showed extensive bilateral airspace opacities consistent with ARDS. He initially received intravenous vancomycin and piperacillin tazobactam for 7 days, but on account of inadequate clinical response was changed to aztreonam and clindamycin with better clinical response. Our patient improved gradually over the next 15 days. After his acute kidney injury, rhabdomyolysis, and ARDS resolved, he was discharged to the psychiatry unit for further management of his severe depression.
zyme and also glucuronidation ( 1 ). In the setting of an overdose, the clinical consequences are thought to be due to the ability of TCAs to block cardiac fast sodium channels and antagonize the central and peripheral muscarinic acetylcholine receptors, peripheral alpha adrenergic receptors, histamine H1 receptors, and central nervous system GABA A receptors. Th e clinical picture is also compounded by the presence of signifi cant drug enterohepatic circulation and active metabolites of the drug following glucuronidation. It is diffi cult to predict drug kinetics when dosed therapeutically, as other eff ects such as acidemia, CYP2DC saturation, and decreased gut motility (from anticholinergic eff ects) help potentiate drug action ( 1 ) .
Based on the clinical circumstances, our patient received treatment with activated charcoal for gastric decontamination, intravenous sodium bicarbonate, lipid rescue, and plasmapheresis. He was also intubated and mechanically ventilated initially for airway protection following cardiopulmonary resuscitation and then for management of ARDS. His refractory hypotension was treated with intravenous fl uids and vasopressors, fl uid administration being adjusted as appropriate because of the concomitant ARDS.
ARDS following TCA overdose has been reported infrequently in the literature over the last 20 to 30 years ( 18 , 19 ) . Th e exact mechanisms at play are not clearly defi ned but may relate to the eff ects of prolonged hypotension, aspiration of gastric contents, sepsis, and direct action of the drugs on the lung parenchyma. We treated our patient with antibiotics in the belief that he aspirated during the acute phase of TCA toxicity, as his mental status rapidly deteriorated with concomitant seizures and cardiopulmonary arrest and subsequent cardiopulmonary resuscitation.
Treatment with sodium bicarbonate remains the standard of care for TCA poisoning ( 1 ). Th is induces an alkalosis and provides a sodium load that helps improve cardiac conduction. Th e sodium loading also helps treat the ensuing hypotension seen in many patients. Alkalosis helps reduce the amount of free drug by increasing protein binding. However, the toxicity profi le and the clinical instability of some patients in spite of sodium bicarbonate administration have necessitated the trial of other adjunctive therapies such as lipid emulsion treatment and plasmapheresis, as with our patient. In view of the lack of randomized trials that have demonstrated eff ectiveness, these treatments remain controversial and are not yet recommended by the standard treatment guidelines ( 1 , 20 ) . Another issue that presents a dilemma to clinicians is the fact that there is no certain method to determine that sodium bicarbonate has failed and that other treatments need be instituted. Clinicians tend to initiate other treatments depending on disease severity
DISCUSSION
Our patient unsuccessfully attempted suicide with amitriptyline and possibly other medications. It has been estimated that 97% of the deaths from antidepressants are from TCAs ( 1 -3 ). Our patient manifested classic clinical complications of TCA overdose, specifi cally the development of life-threatening arrhythmias (QRS prolongation, ventricular tachycardia/fi brillation), seizures, and hypotension. He also developed rhabdomyolysis, acute kidney injury, and ARDS, which although not as common have been reported following TCA overdose. Rhabdomyolysis has been reported as a rare complication following TCA overdose ( 8 ) . Th e Table reviews other cases of TCA overdose, describing the patient's clinical features, as well as the interventions and their outcomes ( 3 , 5 , 9 -16 ).
Ventricular fi brillation following TCA overdose has been reported in about 2% to 4% of cases and is more common in severe poisonings involving extreme QRS widening and QT prolongation ( 1 ). Our patient had very impressive QRS prolongation, up to 170 ms. QRS duration is thought to be a better predictor of morbidity than the plasma level of the TCA ( 1 , 17 ) . A duration >160 ms predicts a 50% chance of life-threatening ventricular arrhythmias ( 1 , 17 ) . A QRS duration >100 ms is an indication for bicarbonate therapy in the setting of TCA overdose ( 1 ) . Electrocardiographic signs suggestive of toxicity include QRS duration >100 ms, abnormal QRS morphology, and abnormal size and ratio of the R and S waves in lead AVR, specifi cally R wave in AVR >3 mm and R to S ratio in AVR >0.7. Other cardiac manifestations of toxicity include the development of a bundle branch block, commonly a right bundle branch block ( 1 , 17 ) .
Th e TCAs exert their pharmacologic eff ects by the inhibition of presynaptic serotonin and norepinephrine uptake. TCAs are rapidly absorbed from the gut and reach high plasma levels within 2 to 8 hours. Th ey have a high volume of distribution on account of their high lipid solubility. In plasma, TCAs circulate bound to alpha 1 acid glycoprotein. Th ey undergo phase 1 metabolism in the liver with the action of the CYP2D6 en- and response of electrocardiographic and hemodynamic parameters ( 1 ). Lipid emulsion therapy is thought to work by counteracting the activity of lipophilic drugs, like the TCA drugs. Its use was fi rst demonstrated in anesthetic agent overdose and gradually began to be used in TCA poisoning. It is thought to be able to sequester the ingested TCAs. Th ere are multiple case reports of dramatic clinical response in cases of severe TCA poisoning managed with adjunctive intralipid administration in addition to sodium bicarbonate infusion ( 3 , 7 , 20 ) .
Plasmapheresis involves the removal of the patient's plasma and replacement with another fl uid (e.g., allogeneic donor plasma, colloid, crystalloid). Th is is useful in TCA poisoning because of the high lipid solubility and binding of TCAs. Reductions in plasma levels as much as 63% have been reported after plasmapheresis for TCA poisoning ( 5 ) . Th e use of plasmapheresis in TCA poisoning has been controversial; while several case reports have suggested good outcomes following its use ( 1 , 5 , 6 , 16 ) , the Extracorporeal Treatments in Poisoning (EXTRIP) Working Group recommended against the use of plasmapheresis and extracorporeal treatment for TCA poisoning, citing the insuffi cient data regarding the benefi ts and eff ectiveness of plasmapheresis ( 8 ) . Our report adds to the collection of clinical case reports where adjunctive plasmapheresis and lipid rescue have been associated with a good outcome in TCA overdose.
